Fine Foods & Pharmaceuticals NTM SpA (FRA:9S5) EV-to-EBIT : 19.88 (As of Jan. 18, 2025)

Fine Foods & Pharmaceuticals NTM SpA EV-to-EBIT Chart

Fine Foods & Pharmaceuticals NTM SpA Quarterly Data
	Jun19	Dec19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
EV-to-EBIT	Get a 7-Day Free Trial															131.33	83.11	86.80	29.63	24.02

Competitive Comparison of Fine Foods & Pharmaceuticals NTM SpA's EV-to-EBIT

For the Packaged Foods subindustry, Fine Foods & Pharmaceuticals NTM SpA's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Fine Foods & Pharmaceuticals NTM SpA's EV-to-EBIT Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Fine Foods & Pharmaceuticals NTM SpA's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Fine Foods & Pharmaceuticals NTM SpA's EV-to-EBIT falls into.

Fine Foods & Pharmaceuticals NTM SpA EV-to-EBIT Calculation

Fine Foods & Pharmaceuticals NTM SpA's EV-to-EBIT for today is calculated as:

Fine Foods & Pharmaceuticals NTM SpA's current Enterprise Value is €221.3 Mil.
Fine Foods & Pharmaceuticals NTM SpA's EBIT for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €11.1 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fine Foods & Pharmaceuticals NTM SpA  (FRA:9S5) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Fine Foods & Pharmaceuticals NTM SpA's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2024 is calculated as:

Fine Foods & Pharmaceuticals NTM SpA's Enterprise Value for the quarter that ended in Sep. 2024 was €254.6 Mil.
Fine Foods & Pharmaceuticals NTM SpA's EBIT for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €11.1 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fine Foods & Pharmaceuticals NTM SpA EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Fine Foods & Pharmaceuticals NTM SpA's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Fine Foods & Pharmaceuticals NTM SpA Business Description